Many patients seen by cardiologists suffer chronic obstructive pulmonary disease (COPD) in addition to their primary cardiovascular problem. Yet, quite often COPD has not been diagnosed and, consequently, patients have not been treated of their pulmonary disease. Recognizing and treating COPD in patients with CVDs is important because optimal treatment of the COPD carries important benefits on cardiovascular outcomes. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) publishes an annual report that serves as a clinical guideline for the diagnosis and management of COPD around the world and has very recently released the 2023 annual report. Here, we provide a summary of the GOLD 2023 recommendations that highlights those aspects of more interest for practicing cardiologists dealing with patients with CVD who may suffer COPD.

心脏病专家接诊的许多患者除了主要的心血管问题外，还患有慢性阻塞性肺病（COPD）。然而，慢性阻塞性肺病常常未被诊断出来，因此，患者的肺部疾病也没有得到治疗。识别和治疗 CVD 患者的 COPD 非常重要，因为 COPD 的最佳治疗对心血管结局具有重要益处。全球慢性阻塞性肺疾病倡议 (GOLD) 发布了一份年度报告，作为世界各地 COPD 诊断和管理的临床指南，并于最近发布了 2023 年年度报告。在此，我们提供了 GOLD 2023 建议的摘要，其中强调了执业心脏病专家在处理可能患有慢性阻塞性肺病 (COPD) 的 CVD 患者时更感兴趣的方面。